ClinicalTrials.govpublic full text
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
cancer of ovary, neoplasms, ovarian, ovarian cancer stage iv, ovarian cancer recurrent, ovarian cancer stage iii, ovary cancer
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 123449 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.